1.
NEJM Evid
; 2(2): EVIDoa2200293, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38320033
RESUMO
Anticoagulation in Non-Critically Ill Covid-19 PatientsMcQuilten et al. conducted a randomized clinical trial comparing low-dose, intermediate-dose, low-dose plus aspirin, and therapeutic-dose anticoagulation in patients with Covid-19 of diverse ethnicities in high-, low-, and middle-income countries.